New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
08:30 EDTAGNAllergan price target raised to $118 from $104 at Argus
Argus increased its target on Allergan as the firm believes that the company reported solid sales and earnings growth ,and has a strong pipeline. The firm expects the company to generate double digit earnings growth over the next three to five years, driven by several positive catalysts. It maintains a Buy rating on the shares.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
17:22 EDTAGNAllergan reports 6.7% stake in KYTHERA
June 25, 2015
08:13 EDTAGNAllergan CEO: Irvine campus ‘crucial’ to company, L.A. Times reports
New Allergan CEO Brent Saunders said that the company’s Irvine, California campus is “crucial” to the recently purchased organization, the L.A. Times reports, citing comments from Saunders in an interview. Allergan was purchased in March by Actavis, a move which led to the layoff of roughly 600 employees from the Irvine offices, the report says. Saunders said that the “bleeding has stopped” after a round of layoffs, the L.A. Times says. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use